Nanomedicines: regulatory challenges and risks ahead

Brian Kelly reports from the first international scientific workshop dedicated to nanomedicines.

Brian Kelly reports from the first international scientific workshop dedicated to nanomedicines.

There are a number of fundamental regulatory and scientific issues that must be addressed before nanomedicines can become everyday medical...

More from Archive

More from Pink Sheet